These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 16315314

  • 21. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
    Potena L, Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke JP, Mocarski ES, Valantine HA.
    Transplantation; 2006 Aug 15; 82(3):398-405. PubMed ID: 16906040
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection.
    Dickenmann MJ, Kabulbayev K, Steiger J, Cathomas G, Reusser P, Tamm M.
    Clin Microbiol Infect; 2004 Apr 15; 10(4):337-9. PubMed ID: 15059125
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Aciclovir or ganciclovir universal prophylaxis of cytomegalovirus infection in liver transplantation: an economic analysis.
    Leong RW, Smith DW, Garas G, Beaman JM, Mitchell AW, Heath DI, House AK, Jeffrey GP.
    Intern Med J; 2004 Jul 15; 34(7):410-5. PubMed ID: 15271175
    [Abstract] [Full Text] [Related]

  • 26. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation.
    Lianghui G, Shusen Z, Tingbo L, Yan S, Weilling W, Anwei L.
    Transplant Proc; 2004 Jun 15; 36(5):1502-5. PubMed ID: 15251371
    [Abstract] [Full Text] [Related]

  • 27. Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience.
    Perrella A, Esposito C, Ioia G, Campanella L, Taglialatela D, Cuomo O.
    Transplant Proc; 2010 May 15; 42(4):1226-8. PubMed ID: 20534267
    [Abstract] [Full Text] [Related]

  • 28. The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation.
    Sheng L, Jun S, Jianfeng L, Lianghui G.
    Clin Transplant; 2015 Jun 15; 29(6):555-9. PubMed ID: 25851741
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Extended ganciclovir prophylaxis in lung transplantation.
    Perreas KG, McNeil K, Charman S, Sharples LD, Wreghitt T, Wallwork J.
    J Heart Lung Transplant; 2005 May 15; 24(5):583-7. PubMed ID: 15896756
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study.
    Maltezou H, Whimbey E, Abi-Said D, Przepiorka D, Champlin R, Goodrich J.
    Bone Marrow Transplant; 1999 Sep 15; 24(6):665-9. PubMed ID: 10490734
    [Abstract] [Full Text] [Related]

  • 34. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
    Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM.
    Transplantation; 1995 Mar 27; 59(6):851-9. PubMed ID: 7535482
    [Abstract] [Full Text] [Related]

  • 35. The value of pre-emptive therapy for cytomegalovirus after liver transplantation.
    Müller V, Perrakis A, Meyer J, Förtsch T, Korn K, Croner RS, Yedibela S, Hohenberger W, Schellerer VS.
    Transplant Proc; 2012 Jun 27; 44(5):1357-61. PubMed ID: 22664015
    [Abstract] [Full Text] [Related]

  • 36. Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines.
    Dmitrienko S, Balshaw R, Machnicki G, Shapiro RJ, Keown PA.
    Transplantation; 2009 Feb 27; 87(4):570-7. PubMed ID: 19307796
    [Abstract] [Full Text] [Related]

  • 37. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.
    Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kisilisik AT, Trofe J, Alloway RR, Gaber LW, Gaber AO.
    Transpl Infect Dis; 2001 Mar 27; 3(1):8-15. PubMed ID: 11429034
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
    Kuo HT, Ye X, Sampaio MS, Reddy P, Bunnapradist S.
    Transplantation; 2010 Nov 27; 90(10):1091-8. PubMed ID: 20885340
    [Abstract] [Full Text] [Related]

  • 40. Late cytomegalovirus disease following liver transplantation.
    Shibolet O, Ilan Y, Kalish Y, Safadi R, Ashur Y, Eid A, Shouval D, Wolf D.
    Transpl Int; 2003 Dec 27; 16(12):861-5. PubMed ID: 12904846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.